[A cohort study of HIV infection among intravenous drug users in Ruili and other two counties in Yunnan Province, China, 1992-1995]

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

[A cohort study of HIV infection among intravenous drug users in Ruili and other two counties in Yunnan Province, China, 1992-1995]

Chung Hua Liu Hsing Ping Hsueh Tsa Chih. 1997 Oct;18(5):259-62. Unique Identifier : AIDSLINE MED/99029027
Zheng X; Zhang JP; Qu SQ; Institute of Epidemiology and Microbiology, Chinese Academy of; Preventive Medicine, Beijing.

Abstract: Since 1992, cohort study of prevaience of HIV infection and incidence rate among drug users has been conducted annually at the study spots along southwestern border areas of Ruili, Longchuan and Luxi counties, Yunnan province of China. From 1992 to 1995, 859, 437, 343 and 540 drug users with a total number of 2179 cases were studied respectively. The proportion of IDUs among drug users was about 30% in 1992, and went up to about 50% in 1995. HIV serloprevalence rates among IDUs in Ruili was comparatively high. From 1992 to 1995, the rates were 81.8%, 85.7%, 61.8% and 51.9% respectively. Longchuan county was at medium, 44.6%, 40.0%, 42.2% and 43.5% respectively. Luxi kept at a lower level, which were 5.1%, 0%, 0% and 3.1%. From 1992 to 1995, the increase of incidence rates were 30.1% from 21.7% to 42.1% in Ruili county, 17.2% (12.1% to 25.9%) in Long Chuan, and 0.6% (0% to 2.3%) in Luxi. The sero-prevalence rate among the spouses of these HIV infected persons was 3.1% in 1990, but increased to 9.8%, 7.4%, 0% and 10.3% respectively from 1992 to 1995 and was 12.3% in 1997. CD4 counting was conducted in 107 cases. The result indicated at the earlier of the year being infected. The higher proportion of CD4 count which was < 500/mm3 on NASBA was applied to analyse the viral load, 3 out of 29 cases were < 1,000 copies/ml, while Log mean of viral load in 26 cases was 4.37.

Keywords: JOURNAL ARTICLE China/EPIDEMIOLOGY Cohort Studies English Abstract Female Human HIV Infections/*EPIDEMIOLOGY/ETIOLOGY Male Needle Sharing/*STATISTICS & NUMER DATA Prevalence Substance Abuse, Intravenous/*COMPLICATIONS
990330
A9931091

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .